Production (Stage)
Aethlon Medical, Inc.
AEMD
$1.18
-$0.045-3.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -157.89% | 49.37% | 7.50% | 21.66% | 1.68% |
| Total Depreciation and Amortization | -2.21% | -8.42% | -6.13% | -4.65% | 7.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,953.15% | -72.09% | -1.59% | -45.07% | -40.38% |
| Change in Net Operating Assets | 32.29% | -218.83% | 1,430.53% | 30.91% | 53.50% |
| Cash from Operations | 34.80% | 15.43% | 18.10% | 29.60% | 12.94% |
| Capital Expenditure | 144.90% | 75.00% | -- | -- | 56.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 144.90% | 75.00% | -- | -- | 56.64% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4,974.10% | -100.00% | -- | 395.75% | -- |
| Repurchase of Common Stock | 59.72% | 24.47% | 61.22% | 39.29% | -176.92% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5,437.79% | -104.01% | 61.22% | 399.14% | 1,738.46% |
| Foreign Exchange rate Adjustments | -4.35% | -342.86% | 563.64% | -550.00% | 61.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 127.12% | 7.72% | 18.68% | 322.02% | 14.72% |